The aim of research at the DRFZ is to better understand rheumatic diseases, diagnose them early and treat them in a targeted manner. Through cutting-edge research at the cellular and tissue level, we develop innovative, personalised therapies that specifically interrupt the inflammatory process.
We analyse health risks and gaps in care to improve treatment and quality of life for patients. Using artificial intelligence and systems biology methods, we decipher the complex mechanisms of rheumatic diseases, identify biomarkers for early diagnosis and optimise therapies.
